Skip to main content

Table 4 Spearman’s correlation coefficients between 6-month changes in right ventricular indices, biomarkers and blood pressure

From: Impact of empagliflozin on right ventricular parameters and function among patients with type 2 diabetes

Biomarker Empagliflozin 10 mg (n = 44)* Placebo (n = 46)*
RVEDVI RVESVI RVMI RVEF RVEDVI RVESVI RVMI RVEF
NT-pro-BNP, pg/mL 0.04 − 0.06 0.06 0.11 − 0.05 − 0.18 0.06 0.15
High sensitivity troponin I, ng/mL 0.19 0.26 0.17 − 0.16 − 0.02 − 0.15 0.07 0.26
Systolic blood pressure 0.03 0.06 0.04 0.03 0.15 0.26 − 0.02 − 0.21
Diastolic blood pressure − 0.10 − 0.09 0.01 0.06 0.06 0.13 0.12 − 0.19
  1. NT-pro-BNP, NT-pro B-natriuretic peptide
  2. *All p-values are non-significant